InsiderTrades

Thye Dirk

SEC CIK 1638945 · EDGAR

Buying vs selling by month open-market trades, last 38 months, QNCX
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
QNCXQuince Therapeutics, Inc.CEO, Dir 255.0K $317.5K — 92022-05-192025-12-10

Most active insiders at QNCX, 12 months

#InsiderTitleBoughtSold
1 Benatti LucaDir —$173.5K
2 Hannah BrendanCOO, CCO, CBO ——
3 Thye DirkCEO, CMO, Dir ——

Transactions 9

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
2025-12-12 2025-12-10 QNCX Quince Therapeutics, Inc. Thye Dirk CEO, CMO, Dir G - Gift $0.00 -739.9K 255.0K -74% $0
I 2025-12-12 2025-12-10 QNCX Quince Therapeutics, Inc. Thye Dirk CEO, CMO, Dir G - Gift $0.00 +739.9K 739.9K New $0
D 2025-06-23 2025-06-18 QNCX Quince Therapeutics, Inc. Thye Dirk CEO, CMO, Dir A - Grant $1.20 +150.9K 994.9K +18% +$181.1K
M 2024-09-03 2024-08-29+ QNCX Quince Therapeutics, Inc. Thye Dirk CEO AND Chief MEDICAL Off, Dir P - Purchase $0.695 +154.5K 843.9K +22% +$107.4K
DM 2024-01-17 2024-01-16 QNCX Quince Therapeutics, Inc. Thye Dirk CEO, Dir M - OptEx $0.7932 +240.5K 539.4K +80% +$190.8K
2023-08-11 2023-08-10 QNCX Quince Therapeutics, Inc. Thye Dirk CEO, Dir P - Purchase $1.26 +88.0K 448.9K +24% +$110.9K
2023-08-09 2023-08-08 QNCX Quince Therapeutics, Inc. Thye Dirk CEO, Dir P - Purchase $1.24 +80.0K 360.9K +28% +$99.2K
A 2022-05-27 2022-05-19 QNCX Quince Therapeutics, Inc. Thye Dirk CEO, Dir A - Grant $0.00 +216.3K 280.9K +335% $0
D 2022-05-23 2022-05-19 QNCX Quince Therapeutics, Inc. Thye Dirk CEO, Dir A - Grant — +64.6K 64.6K New —

Purchase Sale Sale after option exercise All abbreviations